Yangbing Li

Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression

Yangbing Li, Jiuling Yang, Angelo Aguilar et al. · Journal of Medicinal Chemistry · 2018 · 299 citations · Full text

Medicine, Oncology, Pharmacology +10

Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders

Jiuling Yang, Yangbing Li, Angelo Aguilar et al. · Journal of Medicinal Chemistry · 2019 · 173 citations · Full text

Life Sciences, Molecular Biology, Oncology +7

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions

Diana Bradford, Erin Larkins, Sirisha L. Mushti et al. · Clinical Cancer Research · 2020 · 167 citations

Medicine, Oncology, Molecular Oncology +12

Soil erosion evolution and spatial correlation analysis in a typical karst geomorphology using RUSLE with GIS

Cheng Zeng, Shijie Wang, Xiaoyong Bai et al. · Solid Earth · 2017 · 115 citations · Full text

Natural Sciences, Earth Sciences, Soil Sciences +17

Responses of carbon and water use efficiencies to climate and land use changes in China's karst areas

Biqin Xiao, Xiaoyong Bai, Cuiwei Zhao et al. · Journal of Hydrology · 2022 · 114 citations

Natural Resources, Environmental Sciences, Hydrology +14